ChemicalBook > Product Catalog >Pharmaceutical intermediates >Heterocyclic compound >Pyrimidines >Amines >2,6-difluoro-3,5-diMethoxybenzenaMine

2,6-difluoro-3,5-diMethoxybenzenaMine

2,6-difluoro-3,5-diMethoxybenzenaMine Suppliers list
Company Name: Sichuan aibike Pharmaceutical Technology Co., Ltd  Gold
Tel: 028-68517313 18428121256
Email: wangxinlong@emtco.cn
Company Name: Suzhou Haoyi Biotechnology Technology Co., Ltd.  Gold
Tel: 15995756885
Email: 15995756885@139.com
Company Name: Energy Chemical  
Tel: 400-0056266
Email: sales8178@energy-chemical.com
Company Name: WUHAN SUN-SHINE BIO-TECHNOLOGY Co., Ltd.  
Tel: 17702719238
Email: sales@sun-shinechem.com
Company Name: ShangHai Caerulum Pharma Discovery Co., Ltd.  
Tel: 18149758185 18149758185
Email: sales-cpd@caerulumpharma.com

2,6-difluoro-3,5-diMethoxybenzenaMine manufacturers

2,6-difluoro-3,5-diMethoxybenzenaMine Basic information
Product Name:2,6-difluoro-3,5-diMethoxybenzenaMine
Synonyms:2,6-difluoro-3,5-diMethoxybenzenaMine;2,6-difluoro-3,5-dimethoxybenzeneamine;2,6-difluoro-3,5-dimethoxy-phenylamine;PEMIGATINIB INT1;Benzenamine, 2,6-difluoro-3,5-dimethoxy-;Pemetinib intermediate;Chlorpyrifos Impurity 8 (Profenofos);2,6-Difluoro-3,5-dimethoxyaniline
CAS:651734-54-2
MF:C8H9F2NO2
MW:189.16
EINECS:200-100-8
Product Categories:
Mol File:651734-54-2.mol
2,6-difluoro-3,5-diMethoxybenzenaMine Structure
2,6-difluoro-3,5-diMethoxybenzenaMine Chemical Properties
Boiling point 301.0±37.0 °C(Predicted)
density 1.276±0.06 g/cm3(Predicted)
storage temp. under inert gas (nitrogen or Argon) at 2–8 °C
pka0.97±0.10(Predicted)
AppearanceLight brown to brown Solid
InChIInChI=1S/C8H9F2NO2/c1-12-4-3-5(13-2)7(10)8(11)6(4)9/h3H,11H2,1-2H3
InChIKeySUXITUVUFUOAGT-UHFFFAOYSA-N
SMILESC1(N)=C(F)C(OC)=CC(OC)=C1F
Safety Information
HS Code 2922190090
MSDS Information
2,6-difluoro-3,5-diMethoxybenzenaMine Usage And Synthesis
Uses2,6-Difluoro-3,5-dimethoxyaniline is an organic compound used primarily as an organic synthesis intermediate and a pharmaceutical intermediate, especially in laboratory research and development and chemical production processes. The compound is a key intermediate in the drug pemigatinib, used to treat certain types of cancer.
Synthesis
Carbamic acid, N-(2,6-difluoro-3,5-dimethoxyphenyl)-, 1,1-dimethylethyl ester

651734-57-5

2,6-difluoro-3,5-diMethoxybenzenaMine

651734-54-2

Tert-butyl 2,6-difluoro-3,5-dimethoxyphenylcarbamate (34.6 g, 0.12 mol) was added to 120 mL of trifluoroacetic acid and stirred until completely dissolved to form a homogeneous solution. The reaction mixture was stirred at room temperature for 30 minutes. Upon completion of the reaction, the solvent was removed by distillation under reduced pressure. To the residue, saturated sodium bicarbonate solution was slowly added to adjust the pH to 8. The resulting suspension was extracted twice with diethyl ether (appropriate amount each time). The organic phases were combined, washed once with saturated saline, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to give 22 g of 2,6-difluoro-3,5-dimethoxyaniline in 97% yield. The mass spectrum (APCI) showed (M+1)/z of 190.1.

References[1] Patent: WO2006/38112, 2006, A1. Location in patent: Page/Page column 28
[2] Patent: US2004/19210, 2004, A1. Location in patent: Page 13
2,6-difluoro-3,5-diMethoxybenzenaMine Preparation Products And Raw materials
Raw materials2,6-difluoro-3,5-dimethoxy benzoic acid-->Carbamic acid, N-(2,6-difluoro-3,5-dimethoxyphenyl)-, 1,1-dimethylethyl ester-->Sodium bicarbonate
Tag:2,6-difluoro-3,5-diMethoxybenzenaMine(651734-54-2) Related Product Information
Benzenamine, 2,6-difluoro-3-methoxy- (9CI) 2-Fluoro-3-methoxyaniline N-Benzyl-2,6-difluoro-3,5-dimethoxyaniline 3,5-DiMethoxy-2-fluoroaniline 2,4-Difluoro-5-methoxyaniline Benzenamine, 4-fluoro-3,5-dimethoxy-